We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biotrin Announces Agreement with BD Biosciences
News

Biotrin Announces Agreement with BD Biosciences

Biotrin Announces Agreement with BD Biosciences
News

Biotrin Announces Agreement with BD Biosciences

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Biotrin Announces Agreement with BD Biosciences "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biotrin has announced an agreement with BD Biosciences, a segment of BD (Becton, Dickinson and Company), for the distribution of Biotrin's biomarker range of products for the detection of early organ damage.

Under the terms of the distribution agreement, BD Biosciences has been appointed as world-wide distributor of the Biotrin Biomarkers product range to pharmaceutical companies, contract research organisations, universities and research centres.

"We believe this agreement will enable us to capitalize on the growing demand for our expanding biomarker product line and help achieve our goal of making Biotrin Biomarkers the number one choice for the detection of early organ damage," said Dr. Cormac G. Kilty, CEO of Biotrin.

"With the sales and marketing teams from Biotrin and BD Biosciences working together, we will expand the reach of this product line throughout the world."

Biotrin identifies and selects biomarkers of interest using proprietary HISTOMICS® technology.

Biotrin Biomarkers are designed to provide specific and quantitative information allowing researchers to determine the exact location and amount of damage an organ has undergone and to monitor the progression of damage, either as a result of disease or the administration of toxic compounds.

Under the agreement, BD Biosciences will sell the Biotrin Biomarkers product range throughout the world.

Advertisement